205. Usefulness of clozapine as maintenance pharmacotherapy after response to acute electroconvulsive therapy in schizophrenia
Abstract Background Treatment-resistant schizophrenia (TRS)—defined as insufficient response to at least two different atypical antipsychotics—affects approximately 20–33% of individuals with schizophrenia and has been linked to dopamine D₂-receptor supersensitivity. Although clozapine is the internationally recommende...